The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of talquetamab on responses in patients with relapsed and refractory multiple myeloma with prior exposure to T-cell directed therapies.
 
Allison Graeter
No Relationships to Disclose
 
Omar Alexis Castaneda Puglianini
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene/Juno; Legend Biotech
 
Doris K. Hansen
Consulting or Advisory Role - ristol-Meyers Squibb, Karyopharm, Janssen, Pfizer, Legend Biotech USA Inc
Research Funding - Bristol-Meyers Squibb, Karyopharm
 
Mariola A. Vazquez-Martinez
No Relationships to Disclose
 
Brandon Jamaal Blue
Honoraria - Abbvie; Janssen Oncology; Kite, a Gilead company; Oncopeptides; Pfizer
Consulting or Advisory Role - Janssen
Speakers' Bureau - Sanofi
 
Sushmita Khadka
Employment - Guthrie Medical Group (I); Guthrie Medical Group (I)
 
Hien Liu
Honoraria - BioLineRx
Consulting or Advisory Role - BioLineRx
 
Jose L. Ochoa-Bayona
No Relationships to Disclose
 
Ciara L. Freeman
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; ONK Therapeutics
Research Funding - Bristol-Myers Squibb/Celgene
 
Frederick L Locke
Consulting or Advisory Role - A2 Biotherapeutics; Alimera Sciences; Amgen; Bluebird Bio; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Calibr; Caribou Biosciences; Celgene; Cowen; Daiichi Sankyo/UCB Japan; EcoR1 Capital; Gerson Lehrman Group; Iovance Biotherapeutics; Janssen; Kite, a Gilead company; Legend Biotech; Miltenyi Biotec; Novartis; Sana Biotechnology; Takeda; Takeda; Umoja Biopharma
Research Funding - Alimera Sciences (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Kite, a Gilead company
 
Taiga Nishihori
Consulting or Advisory Role - Immunogen
Research Funding - Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Kenneth H. Shain
Honoraria - Amgen; Bristol Myers Squibb (Celgene); GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; GlaxoSmithKline; Janssen Oncology
Speakers' Bureau - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen Oncology; Sanofi; Takeda
Research Funding - Abbvie; Karyopharm Therapeutics
 
Rachid C. Baz
Honoraria - Hikma Pharmaceuticals
Consulting or Advisory Role - BMS; Janssen; Pfizer; Sanofi
Research Funding - Abbvie (Inst); Arvinas (I); BMS (Inst); Daiichi Sankyo/Lilly (I); Janssen (Inst); Karyopharm Therapeutics (Inst); Marker Therapeutics (I); Pionyr (I); Quantum Leap Healthcare Collaborative (I); Regeneron (I); Seagen (I); Zymeworks (I)
Other Relationship - GlaxoSmithKline
 
Melissa Alsina
Honoraria - BMS, Janssen, Sanofi
Consulting or Advisory Role - Janssen,BMS
Research Funding - BMS Brazil
Travel, Accommodations, Expenses - Janssen
 
Ariel Felipe Grajales-Cruz
Consulting or Advisory Role - Cellectar; Sanofi
Speakers' Bureau - Amgen; Sanofi